Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BTL-899ST

K-Number: K202199 · 2021-01-26

ApplicantBtl
Decision Date2021-01-26
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

BTL-899ST is the device name listed in this FDA 510(k) record. The listed applicant is Btl. It received FDA 510(k) clearance on 2021-01-26 under 510(k) number K202199. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BTL-899ST?

BTL-899ST is a medical device that received FDA 510(k) clearance on 2021-01-26. The listed applicant is Btl. The 510(k) number is K202199.

When did BTL-899ST receive FDA 510(k) clearance?

BTL-899ST received FDA 510(k) clearance on 2021-01-26, under 510(k) number K202199.

Who is the listed applicant for BTL-899ST?

The FDA 510(k) record lists Btl as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BTL-899ST?

The FDA product code for BTL-899ST is GEI.

Other records listing Btl as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GEI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.